CAMP4 Therapeutics logoCT

CAMP4 Therapeutics

Verified

BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech

About CAMP4 Therapeutics

CAMP4 Therapeutics is tracked on 100Xfounder as a biotech company, founded in 2016, based in Boston, Massachusetts, USA, currently mapped to the Series B stage. BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech

Profile snapshot: Founders linked: CAMP4 Therapeutics Team. Funding tracked: $100.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

  • CAMP4 Therapeutics appears in the 100Xfounder startup directory import feed.

Why it Matters

CAMP4 Therapeutics is worth tracking because its funding history is already mapped here, including a $100.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and CAMP4 Therapeutics Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $100.00MLast Round: Series B Andreessen Horowitz, $100M Series B in 2022All Rounds: 1
  • Series B | Andreessen Horowitz, $100M Series B in 2022

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: April 20, 2026

CAMP4 Therapeutics research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech

  • Founders covered

    CAMP4 Therapeutics Team

  • Market position

    Biotech | Series B | Boston, Massachusetts, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $100.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Biotech with comparable market signals.

Discover Now

Newsroom and topic pages connected to CAMP4 Therapeutics.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About CAMP4 Therapeutics

Common questions people ask about this profile.

What is CAMP4 Therapeutics?

BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech

Who founded CAMP4 Therapeutics?

CAMP4 Therapeutics is associated with CAMP4 Therapeutics Team on 100Xfounder.

Where is CAMP4 Therapeutics located?

CAMP4 Therapeutics is listed in Boston, Massachusetts, USA.

What stage is CAMP4 Therapeutics in?

CAMP4 Therapeutics is currently mapped to Series B. Funding context: Andreessen Horowitz, $100M Series B in 2022

What is the latest funding round of CAMP4 Therapeutics?

CAMP4 Therapeutics's latest tracked round is Series B Andreessen Horowitz, $100M Series B in 2022. Total tracked rounds: 1.

Is CAMP4 Therapeutics hiring now?

CAMP4 Therapeutics hiring status: Open Roles.

What technologies does CAMP4 Therapeutics use?

CAMP4 Therapeutics is associated with AWS, React, Python, and PostgreSQL.

Is CAMP4 Therapeutics verified on 100Xfounder?

Yes. CAMP4 Therapeutics is currently marked verified on 100Xfounder as of April 20, 2026.

How can users connect with CAMP4 Therapeutics founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.